Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combination or Sequential Therapy of Peg-IFNα-2a and Entecavir for HBeAg-positive CHB
NCT01906580Phase 4Unknown
- Sponsor
- The Fifth Medical Center of the PLA General Hospital
- Start
- Jul 2011
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of entecavir in Chronic Hepatitis B (CHB), sponsored by The Fifth Medical Center of the PLA General Hospital. Status: unknown.
02
Drugs
entecavir
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT01906580.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01906580.